CohBar Discovers Novel Peptide Inhibitors of CXCR4, a Key Regulator of Tumor Growth and Metastasis Jan 8, 2020
CohBar Confirms Anti-fibrotic Effect of a Novel Peptide in a Therapeutic Model of Idiopathic Pulmonary Fibrosis Dec 16, 2019
CohBar Completes Phase 1a and Initiates Phase 1b Stage of Clinical Trial of CB4211 Under Development for NASH and Obesity Nov 5, 2019
CohBar to Announce 2019 Third Quarter Financial Results and Provide Business Update on November 6, 2019 Oct 24, 2019
